COMMUNIQUÉS West-GlobeNewswire

Philips and Ibex expand partnership to enhance AI-enabled pathology workflows for better patient care
24/03/2025
March 24, 2025 Interoperable AI-powered digital pathology workflows support confident cancer diagnosis Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today [...]
Recovery First Treatment Center’s New Executive Director Pledges to Expand Access, Strengthen Addiction Treatment Services
24/03/2025
HOLLYWOOD, Fla., March 24, 2025 (GLOBE NEWSWIRE) -- As the overdose crisis continues to affect communities across South Florida, Recovery First Treatment Center has appointed Mercy Estevez, MSW, LCSW, as its new [...]
CARBOGEN AMCIS Secures GMP Certification After Successful ANSM Inspection for its Aseptic Drug Product Manufacturing Site
24/03/2025
BUBENDORF, Switzerland, March 24, 2025 (GLOBE NEWSWIRE) -- Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to [...]
Après une inspection réussie de l’ANSM, CARBOGEN AMCIS obtient la certification BPF pour son site de fabrication de produits pharmaceutiques aseptiques
24/03/2025
BUBENDORF, Suisse, 24 mars 2025 (GLOBE NEWSWIRE) -- CARBOGEN AMCIS, société suisse leader dans le développement de procédés pharmaceutiques et la fabrication d’ingrédients pharmaceutiques actifs (API), a le plaisir d’ [...]
Anaptys Announces Stock Repurchase Plan
24/03/2025
SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that its Board of Directors [...]
Advanced Medical Balloons announces its new hygh-tec Odor Solution™ product, broadening its catheter portfolio
24/03/2025
hygh-tec Odor Solution™ will be launched in Q2 2025 FDA clearance and MDR certification already secured First generation hygh-tec™ catheter rapidly achieved more than a third of the market share in Germany, and [...]
Survey Projects High Turnover Rates Among Healthcare Executives in 2025
24/03/2025
46% Plan to Leave Their Organizations in the Next 12 Months DALLAS, March 24, 2025 (GLOBE NEWSWIRE) -- Close to half of hospital, medical group and other healthcare facility leaders intend to leave their organizations [...]
PharmAla Contracts with Partner to Act as US Distributor
24/03/2025
TORONTO, March 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]
PathAI Expands AISight® Digital Pathology Adoption with Four New Laboratory Partners
24/03/2025
BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology, is pleased to announce that Annapath Pathology Services, Inc. , Peninsula Pathology Medical Group (PPMG) , Pathology Group of [...]
Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases
24/03/2025
Company prioritizes ophthalmology pipeline programs with potential to provide new or improved treatment options in multiple severe and disabling eye diseases Announces an oversubscribed financing of $175 million in [...]
Can-Fite Initiates Pivotal Phase 3 Psoriasis Study of its Oral Drug Piclidenoson with FDA & EMA-Approved Protocol
24/03/2025
The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugs Ramat Gan, Israel, March 24, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a [...]
Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort
24/03/2025
CINCINNATI, March 24, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: ONCO) ("Onconetix" or the “Company”), (formerly Blue Water Biotech, Inc. (BWV)), a cancer diagnostics company focused on the research, development [...]
Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea
24/03/2025
Initial distribution of Emrosi to pharmacies ongoing First prescriptions of Emrosi filled SCOTTSDALE, Ariz., March 24, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a [...]
Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose
24/03/2025
Therapeutic effects were sustained off treatment, with persistent reduction in HbA1c and improvement in beta-cell function 3 months after last dose, suggesting disease-modifying potential of icovamenib Strong [...]
ICU Medical to Present at the 24th Annual Needham Virtual Healthcare Conference
24/03/2025
SAN CLEMENTE, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present [...]
Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors
24/03/2025
MONTREAL, March 24, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ”, “the Company ”, “ us ” or “ we ”) ( TSXV: LOVE ) ( OTCQB: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of premium-grade cannabis [...]
Cannara Biotech annonce la nomination de Justin Cohen au conseil d’administration
24/03/2025
MONTRÉAL, 24 mars 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara » , la « Société » , « nous » ou « notre ») ( TSXV : LOVE ) ( OTCQB : LOVFF ) ( FRA : 8CB0 ), producteur verticalement intégré de cannabis [...]
Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models
24/03/2025
Robust Evidence of Disease Reversal in Severe Knock Out Mice Model Supports Tenaya’s Clinical Development Plan to Evaluate TN-201 as a Potential Treatment for Patients with MYBPC3-associated Hypertrophic Cardiomyopathy [...]
Prostazen Ingredients Backed by Science: What You Should Know
24/03/2025
LAKELAND, Fla., March 24, 2025 (GLOBE NEWSWIRE) -- In the realm of men's health, particularly as they age, prostate health emerges as a crucial concern. The prostate gland plays a vital role in male reproductive health [...]

Pages